Gennova has developed an Omicron specific vaccine GEMCOVAC-OM which has been assessed for its safety and immunogenicity when administered a...

Consolidated total revenue from operations stood at Rs 3,655 crore during the quarter under review as compared to Rs 3,633 crore in the yea...

The Ahmedabad-based drugmaker has also entered into a definitive agreement with Shilpa Medicare Ltd, a contract manufacturing organisation,...

The Indian government will initially introduce Cadila Healthcare's Covid-19 vaccine ZyCoV-D in seven states, including Maharashtra and West...

Zydus Cadila's COVID-19 vaccine ZyCov-D, which has been cleared by India's drug regulator for those aged 12 years and above, will only be a...

Zydus Cadila has the drug regulator's emergency use authorisation to administer its Covid vaccine, ZyCoV-D, in children aged 12-18 years. A...

"India, which lives on Sewa Paramo Dharma (service is the main duty), is engaged in vaccination development and manufacturing despite limit...

The Indian drug regulator has given emergency use authorisation (EUA) to Zydus Cadila's three-dose Covid-19 vaccine, the ministry of scienc...

Based on more than three million nose and throat swabs taken across Britain, the Oxford University study found that 90 days after a second ...

The drug regulator will consider emergency use approval for Covid vaccines developed by Zydus Cadila for children above 12 this week. The r...

Pharmaceutical major Zydus Cadila has told the Centre that it could apply for emergency use authorisation (EUA) for ZyCoV-D vaccine in the ...

About 10 million of such cases were predicted to happen within a 2-3 weeks window, resulting in hospitalisations overwhelming our hospitals...

The company will now be initiating Phase III clinical trials in around 30,000 volunteers.

"The front runner COVID vaccines being launched in India would need a 0.5ml AD syringe for intramuscular drug delivery we are informed. In ...

Antibodies from animals have been used to control many viral and bacterial infections such as rabies, hepatitis B, vaccine virus, tetanus, ...

If proven effective, this process could help more people get vaccinated and make Covaxin cheaper as it requires lesser amount of vaccine. I...

Zydus Cadila's move to begin human trials of its indigenously developed vaccine candidate for COVID-19 is an important milestone for an 'At...